Nutex Health Inc(NUTX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 14 at 7:46 PM ET (Korea 9/15 08:46)
Full metrics table
| Index | RUT | P/E | 8.59 | EPS (ttm) | 25.28 | Insider Own | 32.87% | Shs Outstand | 6.8M | Perf Week | 12.31% |
| Market Cap | 1.49B | Forward P/E | 7.79 | EPS next Y | 0.28% | Insider Trans | 0.02% | Shs Float | 4.6M | Perf Month | 16.17% |
| Enterprise Value | 1.74B | PEG | 0.23 | EPS next Q | 5.71 | Inst Own | 43.18% | Short Float | 25.27% | Perf Quarter | 50.29% |
| Income | 0.18B | P/S | 1.76 | EPS this Y | 165.21% | Inst Trans | 1.4% | Short Ratio | 8.14 | Perf Half Y | 144.39% |
| Sales | 0.85B | P/B | 3.77 | EPS next 5Y | 34.22% | ROA | 19.93% | Short Interest | 1.16M | Perf YTD | 31.83% |
| Book/sh | 57.62 | P/C | 7.18 | EPS past 3/5Y | - | ROE | 57.16% | 52W High | 6.38% ($204.00) | Perf Year | 123.29% |
| Cash/sh | 30.24 | P/FCF | 5.42 | Sales past 3/5Y | 58.62% 253.48% | ROIC | 24.87% | 52W Low | 158.39% ($83.99) | Perf 3Y | 586.34% |
| Dividend Est. | - | EV/EBITDA | 4.51 | EPS Y/Y TTM | 155.98% | Gross Margin | 51.26% | Volatility(W/M) | 5.58% 5.19% | Perf 5Y | -58.66% |
| Dividend TTM | - | EV/Sales | 2.05 | Sales Y/Y TTM | 6.88% | Oper. Margin | 43.02% | ATR (14) | 11.2 | Perf 10Y | -97.37% |
| Dividend Ex-Date | - | Quick Ratio | 4.96 | EPS Q/Q | 417.67% | Profit Margin | 21.25% | RSI (14) | 69.78 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5 | Sales Q/Q | -13.62% | SMA20 | 12.57% ($192.79) | Beta | 0.55 | Target Price | $283 |
| Payout | - | Debt/Eq | 0.88 | Earnings | 2026/8/6 | SMA50 | 22.5% ($177.16) | Rel Volume | 1.69 | Prev Close | $200.24 |
| Employees | 944 | LT Debt/Eq | 0.83 | EPS/Sales Surpr. | 89.34% -1.99% | SMA200 | 51.78% ($142.98) | Avg Volume(3M) | 0.14M | Price | $217.02 |
| IPO | 2014/4/24 | Option/Short | No/Yes | Trades | 5849 | Volume | 241,029 | Change | 8.38% |
Company
NUTX is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 Nutex Health (NUTX) is a U.S. healthcare company operating a physician-led, integrated healthcare delivery system. Its model combines micro-hospitals and hospital outpatient departments across multiple states with a risk-bearing network of primary care physicians, and is characterized by rapid revenue growth centered on emergency and high-acuity care.
Over the past 1 year, on the higher side
0% below its 1-year high.
NUTX makes money exceptionally well
43.02% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +165.2% this year.
Tap to view numbers
The stock looks undervalued
Trading at 8.6 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +586.3% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Short interest is a burden
Institutions hold 43.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
XHS 0.02%
RNIN 0.01%
FDM 0.01%
VAMO 0.01%
FOXY 0.01%It ranks #4 in the industry
Based on market cap of $1B.
NUTX $1B PER 8.6
HCA $92B PER 14.3
THC $21B PER 10.2
FMS $12B PER 11.8
FAQ
What kind of company is NUTX?
NUTX belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of NUTX?
The market cap of NUTX is approximately $1.5B, ranking 2,339 within its sector.
What is the P/E ratio of NUTX?
NUTX has a P/E ratio of approximately 8.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for NUTX?
NUTX has recorded a 52-week high of $204.00 and a low of $83.99.
